Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07734753) titled 'Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events' on July 24.
Study Type: Observational
Primary Sponsor: Sanofi
Condition:
Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
Intervention:
Drug: Alirocumab
Recruitment Status: Not recruiting
Date of First Enrollment: July 15, 2025
Target Sample Size: 4006
Countries of Recruitment:
Netherlands
To know more, visit https://clinicaltrials.gov/study/NCT07734753
Disclaimer: Curated by HT Syndication....